Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
Researchers have developed and validated an artificial intelligence (AI)-powered liquid biopsy that accurately identified hepatocellular carcinoma (HCC) based…